DelveInsight’s Coronary Stents Market Insights Report 2030 provides the current and forecast market analysis, individual leading Coronary Stents companies’ market shares, challenges, Coronary Stents Market Drivers, barriers, trends, and key market Coronary Stents companies in the market.
To read more about the latest highlights related to the Coronary Stents Market @ https://www.delveinsight.com/report-store/coronary-stents-market-market
Key Takeaways from the Coronary Stents Market Report
In July 2024, BIOTRONIK launched the maximum allowed diameters (MAD) range for the Orsiro Mission drug-eluting stent, aligning with modern PCI practices and allowing physicians to optimize vessel apposition and adapt to tapered anatomies more effectively. Strategic significance: Advances BIOTRONIK’s DES technology to better serve complex vessel anatomies.
In April 2024, Abbott Laboratories announced U.S. FDA approval of the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System, a dissolving stent designed for patients with chronic limb-threatening ischemia in the below-the-knee region. Strategic significance: Expands Abbott’s bioresorbable scaffold portfolio into below-the-knee applications.
In February 2023, Abbott Laboratories completed the acquisition of Cardiovascular Systems, Inc. for USD 890 million, expanding its stent system product portfolio and interventional vascular device capabilities. Strategic significance: Strengthens Abbott’s global market penetration in interventional vascular devices.
North America is expected to dominate the overall Coronary Stents market during the forecast period.
The principal drivers are the growing prevalence of cardiovascular diseases and increasing risk factors associated with coronary artery disease; the rise in minimally invasive surgeries performed globally; and technological innovations in coronary stents, including bioresorbable scaffold systems.
The leading Coronary Stents Companies include Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cook, Scitech Medical, Lepu Medical Technology (Beijing) Co., Ltd., OrbusNeich Medical Group Holdings Limited, Cordis, Johnson & Johnson Services, Inc., ENDOCOR GmbH & CO. KG, BD, Vascular Concepts, Translumina, and Elixir Medical, among others.
To know more about why North America is leading the market growth in the Coronary Stents Market, Get a snapshot @ https://www.delveinsight.com/report-store/coronary-stents-market-market
Coronary Stents Overview
Coronary stents are medical devices designed to keep arteries open and ensure a continuous flow of blood to the heart muscle. They are commonly employed in angioplasty procedures and percutaneous coronary intervention (PCI) to enhance arterial function by keeping blocked or narrowed arteries open, thereby restoring adequate blood flow, reducing heart damage, and improving health outcomes for patients with coronary artery disease.
Coronary Stents Market Key Growth Drivers
According to the British Heart Foundation (January 2024), around 620 million people worldwide were living with heart disease as of early 2024, with approximately 250 million individuals suffering from coronary heart disease (CHD) in 2021.
According to the Government of the United Kingdom (March 2024), 1,862,500 individuals were diagnosed with coronary heart disease in England for the financial year ending in 2023, driving continued demand for stent-based interventions.
Eurostat data (October 2023) indicated that approximately 1.1 million percutaneous coronary angioplasty procedures were performed across Europe in 2021, with coronary stents inserted and expanded via balloon catheter to support and maintain arterial openness at the blockage site.
Technological advancements in bioresorbable coronary stent systems are contributing to market growth, exemplified by Abbott’s Esprit™ BTK Everolimus Eluting Resorbable Scaffold System, which dissolves over time after opening blocked arteries and delivers Everolimus to facilitate vessel healing.
Recent product approvals continue to accelerate market growth, including Medtronic’s August 2022 CE Mark approval and launch of its Onyx Frontier™ drug-eluting coronary stent, built on the clinical performance of the Resolute Onyx™ platform.
Get a sneak peek at the Coronary Stents Market Dynamics @ https://www.delveinsight.com/report-store/coronary-stents-market-market
Coronary Stents Market Segment Analysis
The Coronary Stents Market by Product Type (Bare Metal Stents, Drug Eluting Stents, and Bioresorbable Scaffolds), Material (Metal [Stainless Steel, Cobalt-Chromium, Platinum-Chromium, Nitinol] and Polymer), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
By Product Type: Drug-Eluting Stents are expected to hold the largest market share during the forecast period, attributed to the increasing prevalence of coronary heart disease. According to the National Heart Foundation of Australia (January 2024), over 590,000 Australians were living with CHD in 2022, accounting for 2% of the total population. Drug-eluting stents significantly reduce the risk of restenosis and lower the incidence of stent thrombosis and myocardial infarction, with newer-generation DES further improving long-term clinical outcomes in cardiovascular disease treatment.
By Geography: North America is expected to dominate the market, driven by the rising prevalence of heart disease and significant advancements in technology and product development. According to the CDC (June 2024), approximately 20.5 million individuals in the United States were living with coronary heart disease in 2021, and CDC data (May 2024) revealed that approximately 702,880 people, equivalent to 1 in every 5 deaths, died from cardiovascular and other circulatory system diseases in the U.S. in 2022. Europe and Asia-Pacific also hold significant growth potential, driven by an aging population and enhanced government funding for cardiovascular disease management.
Coronary Stents Market Competitive Landscape
The Coronary Stents market features established global leaders including Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, and Terumo Corporation, alongside specialized providers such as MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and Elixir Medical. Companies are intensifying R&D efforts to develop advanced drug-eluting and bioresorbable stent technologies, with recent regulatory milestones including Biosensors International’s April 2022 PMDA approval in Japan for its BioFreedom™ Ultra coronary stent system, featuring a polymer- and carrier-free design.
Coronary Stents Companies
Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cook, Scitech Medical, Lepu Medical Technology (Beijing) Co., Ltd., OrbusNeich Medical Group Holdings Limited, Cordis, Johnson & Johnson Services, Inc., ENDOCOR GmbH & CO. KG, BD, Vascular Concepts, Translumina, Elixir Medical, and others.
Coronary Stents Market Restraints
Despite strong momentum, the Coronary Stents market faces material constraints. Product recalls due to malfunctioning and the risk of restenosis may constrain overall market growth during the forecast period.
Interested in knowing the Coronary Stents Market by 2030? Click to get a snapshot of the Coronary Stents Market Trends- https://www.delveinsight.com/report-store/coronary-stents-market-market
Scope of the Coronary Stents Market Report
Coverage- Global
Study Period- 2021 to 2030
Forecast Period- 2024-2030
Coronary Stents Companies- Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cook, Scitech Medical, Lepu Medical Technology (Beijing) Co., Ltd., OrbusNeich Medical Group Holdings Limited, Cordis, Johnson & Johnson Services, Inc., ENDOCOR GmbH & CO. KG, BD, Vascular Concepts, Translumina, Elixir Medical, and others.
Coronary Stents Market Restraints and Regulatory Analysis
Coronary Stents Porter Five Forces Analysis and Market Assessment
Explore more information of the Coronary Stents Market Insights @ https://www.delveinsight.com/report-store/coronary-stents-market-market
Table of Contents
Coronary Stents Market Report Introduction
Coronary Stents Market Executive Summary
Competitive Landscape
Regulatory Analysis
Coronary Stents Market Key Factors Analysis
Coronary Stents Market Porter’s Five Forces Analysis
Coronary Stents Market Assessment
Coronary Stents Market Company and Product Profiles
KOL Views
Project Approach
About DelveInsight
Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kanishk KumarEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/report-store/coronary-stents-market-market
